RAD54B and glioblastoma: Although one study concerning the effectiveness of capecitabine and concurrent radiation therapy for glioblastoma analyzed the expression profiles of eight genes including RAD54B and reported that high RAD54B expression was associated with a poor outcome [14], the clinical significance of RAD54B expression remains unknown particularly in CRC.